elrexfio

Generic: elranatamab-bcmm

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name elrexfio
Generic Name elranatamab-bcmm
Labeler pfizer laboratories div pfizer inc
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

elranatamab 44 mg/1.1mL

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0069-2522
Product ID 0069-2522_0080902a-fc95-4612-8df2-1fd00bbaed23
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761345
Listing Expiration 2027-12-31
Marketing Start 2023-08-15

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00692522
Hyphenated Format 0069-2522

Supplemental Identifiers

RxCUI
2644885 2644891 2644893 2644894
UNII
L0HR9A577V

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name elrexfio (source: ndc)
Generic Name elranatamab-bcmm (source: ndc)
Application Number BLA761345 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 44 mg/1.1mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02) / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)
source: ndc

Packages (1)

Ingredients (1)

elranatamab (44 mg/1.1mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "0080902a-fc95-4612-8df2-1fd00bbaed23", "openfda": {"unii": ["L0HR9A577V"], "rxcui": ["2644885", "2644891", "2644893", "2644894"], "spl_set_id": ["f6fea598-ff58-4a20-b5e8-8a51f37d8beb"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0069-2522-02)  / 1.1 mL in 1 VIAL, SINGLE-DOSE (0069-2522-01)", "package_ndc": "0069-2522-02", "marketing_start_date": "20230815"}], "brand_name": "Elrexfio", "product_id": "0069-2522_0080902a-fc95-4612-8df2-1fd00bbaed23", "dosage_form": "INJECTION, SOLUTION", "product_ndc": "0069-2522", "generic_name": "elranatamab-bcmm", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Elrexfio", "active_ingredients": [{"name": "ELRANATAMAB", "strength": "44 mg/1.1mL"}], "application_number": "BLA761345", "marketing_category": "BLA", "marketing_start_date": "20230815", "listing_expiration_date": "20271231"}